CB Insights today named Univfy in its fourth-annual list of 150 top digital health companies, which highlights 2022’s most promising digital health companies in the world. We are honored that Univfy is recognized as a company to watch in this exciting and global space.

"From reimagining clinical care to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

Univfy was named in the Digital Front Door & Patient Engagement category and recognized as one of 2022’s most promising private digital health companies. Utilizing the CB Insights platform, the research team selected 150 winners from a pool of over 13,000 private companies, including applicants and nominees. They were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. CBInsights is a business analytics platform and global database that provides market intelligence.

Univfy’s use of artificial intelligence (AI) combined with human expertise gives women and couples the best chance of having a baby at lower cost. With the support of Univfy AI and the Univfy Fertility Concierge, fertility patients can make better-informed decisions, resulting in a 2x higher chance of having a baby at 1/3 less cost per patient. Founded based on Stanford University technology, Univfy has published our methods in peer-reviewed clinical research journals and established an extensive global IP portfolio with patents issued in the US and globally.